CN105636646B - 氮杂吲哚化合物、其合成及其使用方法 - Google Patents
氮杂吲哚化合物、其合成及其使用方法 Download PDFInfo
- Publication number
- CN105636646B CN105636646B CN201480046182.4A CN201480046182A CN105636646B CN 105636646 B CN105636646 B CN 105636646B CN 201480046182 A CN201480046182 A CN 201480046182A CN 105636646 B CN105636646 B CN 105636646B
- Authority
- CN
- China
- Prior art keywords
- methyl
- hydrogen
- compound
- mmol
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 C*(C)NC(C(C([C@@](C)C1)=NC2=C(*)C2)=CN1[C@](*)C(*=C(*)*=*)=C*)=O Chemical compound C*(C)NC(C(C([C@@](C)C1)=NC2=C(*)C2)=CN1[C@](*)C(*=C(*)*=*)=C*)=O 0.000 description 7
- ZRQWIWWLKQCBRR-UHFFFAOYSA-N Cc(nc(c(C[n]1c2cccnc2c(C(NCCF)=O)c1)c1)OC)c1F Chemical compound Cc(nc(c(C[n]1c2cccnc2c(C(NCCF)=O)c1)c1)OC)c1F ZRQWIWWLKQCBRR-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3196/CHE/2013 | 2013-07-17 | ||
| IN3196CH2013 | 2013-07-17 | ||
| PCT/US2014/046100 WO2015009525A1 (en) | 2013-07-17 | 2014-07-10 | Azaindole compounds, synthesis thereof, and methods of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105636646A CN105636646A (zh) | 2016-06-01 |
| CN105636646B true CN105636646B (zh) | 2017-12-19 |
Family
ID=51261257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201480046182.4A Active CN105636646B (zh) | 2013-07-17 | 2014-07-10 | 氮杂吲哚化合物、其合成及其使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9163020B2 (enExample) |
| EP (1) | EP3021947B1 (enExample) |
| JP (1) | JP6366709B2 (enExample) |
| KR (1) | KR102301753B1 (enExample) |
| CN (1) | CN105636646B (enExample) |
| AU (1) | AU2014290598B2 (enExample) |
| CA (1) | CA2918487C (enExample) |
| EA (1) | EA028611B1 (enExample) |
| ES (1) | ES2644025T3 (enExample) |
| WO (1) | WO2015009525A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201512197A (zh) * | 2013-08-30 | 2015-04-01 | Hoffmann La Roche | 吡咯并吡啶或吡唑并吡啶衍生物 |
| GB201317363D0 (en) * | 2013-10-01 | 2013-11-13 | Eisai Ltd | Novel compounds |
| ES2997871T3 (en) | 2017-12-06 | 2025-02-18 | Prollergy Corp | Composition and method for reducing allergic response |
| RU2702224C2 (ru) * | 2018-03-29 | 2019-10-07 | Общество С Ограниченной Ответственностью "Мт-Медикалс" | Производные фенил формамидина, обладающие антимикобактериальной активностью |
| CN112543757A (zh) * | 2018-06-15 | 2021-03-23 | 卡迪拉保健有限公司 | 对结核菌具有抗菌活性的缩合氮杂杂芳基化合物 |
| WO2020188405A1 (en) * | 2019-03-20 | 2020-09-24 | Foundation For Neglected Disease Research | Benzimidazoles derivatives as anti-tuberculosis agents |
| CN111393435A (zh) * | 2020-03-16 | 2020-07-10 | 青岛吉澳医药科技有限公司 | 氮杂吲哚酰胺类化合物及其制备方法和用途 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070027140A1 (en) * | 2003-11-24 | 2007-02-01 | Novo Nordisk A/S | N-heteroaryl indole carboxamides and analogues thereof, for use as glcokinase activators in the treatment of diabetes |
| CN101778850A (zh) * | 2007-08-10 | 2010-07-14 | H.隆德贝克有限公司 | 杂芳基酰胺类似物 |
| CN102869661A (zh) * | 2010-03-18 | 2013-01-09 | 韩国巴斯德研究所 | 抗感染化合物 |
-
2014
- 2014-07-10 EA EA201690227A patent/EA028611B1/ru unknown
- 2014-07-10 EP EP14745305.4A patent/EP3021947B1/en active Active
- 2014-07-10 ES ES14745305.4T patent/ES2644025T3/es active Active
- 2014-07-10 CA CA2918487A patent/CA2918487C/en active Active
- 2014-07-10 WO PCT/US2014/046100 patent/WO2015009525A1/en not_active Ceased
- 2014-07-10 JP JP2016526988A patent/JP6366709B2/ja active Active
- 2014-07-10 US US14/327,784 patent/US9163020B2/en active Active
- 2014-07-10 CN CN201480046182.4A patent/CN105636646B/zh active Active
- 2014-07-10 AU AU2014290598A patent/AU2014290598B2/en active Active
- 2014-07-10 KR KR1020167004150A patent/KR102301753B1/ko active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070027140A1 (en) * | 2003-11-24 | 2007-02-01 | Novo Nordisk A/S | N-heteroaryl indole carboxamides and analogues thereof, for use as glcokinase activators in the treatment of diabetes |
| CN101778850A (zh) * | 2007-08-10 | 2010-07-14 | H.隆德贝克有限公司 | 杂芳基酰胺类似物 |
| CN102869661A (zh) * | 2010-03-18 | 2013-01-09 | 韩国巴斯德研究所 | 抗感染化合物 |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2918487C (en) | 2021-08-03 |
| KR20160058757A (ko) | 2016-05-25 |
| EA201690227A1 (ru) | 2016-07-29 |
| BR112016000712A2 (pt) | 2022-03-22 |
| CN105636646A (zh) | 2016-06-01 |
| WO2015009525A1 (en) | 2015-01-22 |
| EA028611B1 (ru) | 2017-12-29 |
| AU2014290598A1 (en) | 2016-02-11 |
| EP3021947A1 (en) | 2016-05-25 |
| CA2918487A1 (en) | 2015-01-22 |
| JP6366709B2 (ja) | 2018-08-01 |
| US9163020B2 (en) | 2015-10-20 |
| EP3021947B1 (en) | 2017-08-23 |
| ES2644025T3 (es) | 2017-11-27 |
| US20150025087A1 (en) | 2015-01-22 |
| JP2016530242A (ja) | 2016-09-29 |
| AU2014290598B2 (en) | 2018-11-08 |
| KR102301753B1 (ko) | 2021-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105636646B (zh) | 氮杂吲哚化合物、其合成及其使用方法 | |
| CN108473499B (zh) | 新颖的吡唑并嘧啶衍生物 | |
| TWI735416B (zh) | 囊腫纖維化症跨膜傳導調節蛋白之調節劑 | |
| TWI694076B (zh) | 三唑并嘧啶化合物及其用途 | |
| EP2755652B1 (en) | N-substituted heterocyclyl carboxamides | |
| EP4233834A2 (en) | Aryl-aniline and heteroaryl-aniline compounds for treatment of birthmarks | |
| CN114423751B (zh) | 用作选择性aurora a抑制剂的新型杂环化合物 | |
| JP2018527398A (ja) | ヘテロ環式化合物およびそれらの使用 | |
| US20160095843A1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of disease | |
| US20230137585A1 (en) | 6-membered heteroarylaminosulfonamides for treating diseases and conditions mediated by deficient cftr activity | |
| JP2020511467A (ja) | ブロモドメインを阻害する４−（１−（１，１−ジ（ピリジン−２−イル）エチル）−６−（３，５−ジメチルイソオキサゾール−４−イル）−１Ｈ−ピロロ［３，２−ｂ］ピリジン−３−イル）安息香酸の結晶形 | |
| TW201302730A (zh) | 吡唑化合物 | |
| TW201934553A (zh) | 含氮雜環醯胺化合物以及其醫藥用途 | |
| CN113660931A (zh) | 用于治疗皮肤癌的芳基苯胺和杂芳基苯胺化合物 | |
| JP2021519312A (ja) | カルパインモジュレーター及びその治療的使用 | |
| TW202104215A (zh) | Ｊａｋ１選擇性激酶抑制劑 | |
| CN113498340A (zh) | 用于治疗皮肤疾病噻吩基苯胺化合物 | |
| US20220280509A1 (en) | Aza-quinoline compounds and uses thereof | |
| TW201625610A (zh) | 萘啶二酮（ｎａｐｈｔｈｙｒｉｄｉｎｅｄｉｏｎｅ）衍生物 | |
| US10207993B2 (en) | Compounds as anti-tubercular agents | |
| CN103613591A (zh) | 作为cMet抑制剂的化合物及其制备方法和用途 | |
| BR112016000712B1 (pt) | Compostos de azaindol, síntese dos mesmos e métodos de uso dos mesmos | |
| AU2020290094B2 (en) | Pyridine and pyrazine derivative for the treatment of CF, COPD, and bronchiectasis | |
| CN118401521A (zh) | 整合素抑制剂及其与其它剂组合的用途 | |
| HK40055987B (zh) | Jak1选择性激酶抑制剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |